Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor
Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as ...
Mainz BioMed NV: Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert ...
Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...
Applied DNA Sciences, Inc.: Applied DNA Reminds Shareholders to Vote Ahead of Special ...
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it ...
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ...
EQS-News: Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal ...
Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...